Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic review
Abstract Background PARP inhibitors are effective in treating ovarian cancer, especially for BRCA1/2 pathogenic variant carriers and those with HRD (homologous recombination deficiency). Concerns over toxicity and costs have led to the search for predictive biomarkers. We present an updated systemat...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00122-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|